Structural Basis of RNA Recognition and Activation by Innate Immune Receptor RIG-I
Authors
Affiliations
Retinoic-acid-inducible gene-I (RIG-I; also known as DDX58) is a cytoplasmic pathogen recognition receptor that recognizes pathogen-associated molecular pattern (PAMP) motifs to differentiate between viral and cellular RNAs. RIG-I is activated by blunt-ended double-stranded (ds)RNA with or without a 5'-triphosphate (ppp), by single-stranded RNA marked by a 5'-ppp and by polyuridine sequences. Upon binding to such PAMP motifs, RIG-I initiates a signalling cascade that induces innate immune defences and inflammatory cytokines to establish an antiviral state. The RIG-I pathway is highly regulated and aberrant signalling leads to apoptosis, altered cell differentiation, inflammation, autoimmune diseases and cancer. The helicase and repressor domains (RD) of RIG-I recognize dsRNA and 5'-ppp RNA to activate the two amino-terminal caspase recruitment domains (CARDs) for signalling. Here, to understand the synergy between the helicase and the RD for RNA binding, and the contribution of ATP hydrolysis to RIG-I activation, we determined the structure of human RIG-I helicase-RD in complex with dsRNA and an ATP analogue. The helicase-RD organizes into a ring around dsRNA, capping one end, while contacting both strands using previously uncharacterized motifs to recognize dsRNA. Small-angle X-ray scattering, limited proteolysis and differential scanning fluorimetry indicate that RIG-I is in an extended and flexible conformation that compacts upon binding RNA. These results provide a detailed view of the role of helicase in dsRNA recognition, the synergy between the RD and the helicase for RNA binding and the organization of full-length RIG-I bound to dsRNA, and provide evidence of a conformational change upon RNA binding. The RIG-I helicase-RD structure is consistent with dsRNA translocation without unwinding and cooperative binding to RNA. The structure yields unprecedented insight into innate immunity and has a broader impact on other areas of biology, including RNA interference and DNA repair, which utilize homologous helicase domains within DICER and FANCM.
Zheng Y, Moorlach B, Jakobs-Schonwandt D, Patel A, Pastacaldi C, Jacob S Commun Biol. 2025; 8(1):121.
PMID: 39863769 PMC: 11762700. DOI: 10.1038/s42003-025-07554-6.
Eupalinolide B inhibits periodontitis development by targeting ubiquitin conjugating enzyme UBE2D3.
Kuang W, Zhuge R, Song P, Yi L, Zhang S, Zhang Y MedComm (2020). 2025; 6(1):e70034.
PMID: 39811801 PMC: 11731104. DOI: 10.1002/mco2.70034.
The Immune Modulatory Role of TIF1 Proteins.
Zhu Q, Xiao Y Adv Exp Med Biol. 2024; 1466:89-99.
PMID: 39546137 DOI: 10.1007/978-981-97-7288-9_6.
Recent developments in understanding RIG-I's activation and oligomerization.
Sikorska J, Wyss D Sci Prog. 2024; 107(3):368504241265182.
PMID: 39091074 PMC: 11297509. DOI: 10.1177/00368504241265182.
An W, Lakhina S, Leong J, Rawat K, Husain M Pathogens. 2024; 13(7).
PMID: 39057788 PMC: 11280125. DOI: 10.3390/pathogens13070561.